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DFor practical purposes, it is then worth mentioning that
complications related to overablation of the left atrium with
bipolar radiofrequency–such as spontaneous wall rupture
or pulmonary vein stenosis–have not been reported so far.
Therefore, either pacing validation of acute block, fol-
lowed by (>2) additional ablations or, alternatively, multiple
(at least 5 or 6) parallel ‘‘blind’’ ablations, might be neces-
sary to grant durable PV isolation after epicardial ablation
with irrigated bipolar radiofrequency.
We are grateful to Professor Bruno Pellegrini for contributing
the artwork. This work would not have been the same without
the contribution of Professor M. A. Mariani, whom we owe for
his knowing review and valuable suggestions.References
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Kent W. Jones (Salt Lake City, Utah). I enjoyed this paper and
I compliment Dr Benussi on his excellent study. I am aware of his
interest in atrial fibrillation and the surgical treatment thereof.
I think he spent a period of time with the pioneer in that field,
Jim Cox, and I also think papers of this sort of very important in
broadening our understanding of the surgical options for treating
arrhythmias.
As you probably know, in the past year an article was published
reviewing more than 62,000 patients from the Society of Thoracic
Surgeons Database who went to the operating room for a cardiac
surgical procedure with a known history of, or presently in, atrial
fibrillation. Only 38% of those patients had a surgical ablative pro-
cedure, about 50% of the patients with mitral valve disease and only
about 25% of patients with aortic valve disease or coronary disease.
There is a huge patient population that we as cardiac surgeons are
not addressing.
I agree that it is important, if one plans to measure exit block and
entrance block, to place two electrodes on the RPV and two elec-
trodes on the left atrium in an attempt to avoid one of the possible
pitfalls that you outlined in your paper, that being the loss of con-
duction and therefore not really monitoring whether there is exit
block or entrance block.
One question or disagreement I have with the terminology in
your paper is that of using the word ‘‘transmurality,’’ which is re-
ally a histologic term rather than an electrical term. You state that
you found evidence of acute conduction block 100% of the time
after crushing tissue with a clamp and heating that tissue. I think
this is the description of a change in tissue impedance rather than
a really adequate description or evidence of transmural injury.
I have a couple of questions, and I will preface them by a couple
of statements or quotes from your paper.
One statement says that the clinical success of atrial fibrillation
ablation depends on persistent transmurality of the lesions. I totally
agree with that. Then you state that there is no correlation between
the number of ablations required to obtain isolation and the final
isolation result at 3 weeks. You also state that there was no clear-
cut correlation between RPV isolation status and clinical outcome
evidenced by the fact that 85% of the patients had conduction block
at 3 weeks, meaning that 15% of those patients had lost their con-
duction block. However, 92% of those patients were in normal
sinus rhythm.diovascular Surgery c Volume 139, Number 5 1135
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DMy first question: Of the 15% of patients who had lost conduc-
tion block, what percent were in that group found to be in normal
sinus rhythm?
Dr Benussi.Actually, of the two patients who reverted to preop-
erative pacing thresholds, one required DC shock and was in sinus
rhythm thereafter. The other patient with total recovery of conduc-
tion fared perfectly after surgery, with stable sinus rhythm and no
need of DC shock. That told us that in such a population of patients
it is not possible to draw anymeaningful inference on a possible cor-
relation between electrophysiologic appropriateness of the ablation
and sinus rhythm recovery.
First of all, there were only 13 patients. Second, because we only
assessed RPV isolation, we did not know anything about the other
4 or 5 ablations that characterized the treatment of these patients.
Dr Jones. Second, the majority of the papers that you cited in the
first part of your presentation were papers from the catheterization
laboratory dealing with transcatheter ablation. I can understand the
need for measuring exit block or block in conduction in those
patients in whom one is using a multiple catheter technique. How-
ever, when one uses a device such as you described with a clamp
across the PVs, and given the lack of correlation that you showed
between the number of applications versus success, and with the
evidence that you showed that there is certainly a disconnect
between the patients with conduction block or loss thereof and
the patients at 3 weeks in normal sinus rhythm, do you still think
there is a need for measuring conduction block in the operating
room knowing that the chance of getting 100% with the type of
bipolar devices we use is very, very good. Why use the time?
Dr Benussi. I think we have two possible ways to proceed on
that: First, we could validate the lines on a routine basis, which
would make our procedures slightly more complex. However,
once it becomes widely accepted that the electrophysiologic appro-
priateness of our ablation procedure translates itself into better
rhythm outcomes, we could well spend those couple of additional
minutes doing PV pacing. The second possibility is that we base
our standard ablation practice on our preliminary results with intra-
operative validation in a pilot initial series of patients. For instance,
if you are using a device that after two parallel ablations proved to
yield total block in 100% of your patients, you could pretty well
rely on blind double ablation in your standard practice. I am afraid
that by not paying attention to these very simple tricks, we will spoil
the enormous advantage the cardiac surgeon has in terms of effi-
cacy of the technology with respect to the electrophysiologists.
Dr Jones.Would it be of interest to do a randomized study mea-
suring exit and/or entrance block in half of these patients, while
measuring neither in the control group, and then comparing the
results using the same time frames as cited in your presentation?1136 The Journal of Thoracic and Cardiovascular SurDr Benussi. That is a good point. However, as said, in a study
like ours, where only one little piece of the whole left ablation pro-
cedure is validated, it is difficult to draw general inferences on the
importance of transmurality in determining the resulting rhythm
outcome. But the evidence is already out there. Many studies on
percutaneous AF ablation found incomplete isolation of the PVs
to be the major predictor of arrhythmia relapse at follow-up. I think
that, far from being enough, an appropriate PV isolation should be
at least the minimal requirement of our procedures as well.
Dr Jones. I have two other very short questions. You said that
you performed electrocardiography, Holter monitoring, and trans-
thoracic echocardiography at 3 months, 6 months, and 12 months,
but you gave no data as to the outcome. Are the patients the same?
Are 92% of them still in normal rhythm at a year?
Dr Benussi. Correct. That was the result from the Holter moni-
toring, which is the base requirement for follow-up, according to
the recommendations of the Heart Rhythm Society consensus.
Dr Jones. I have one short technique question. As I understand
it, you use a purse-string suture on the inside of the left atrium to
obliterate the appendage. Given the data from the Cleveland Clinic
recently showing that 22% of those patients still had an hourglass
narrowing at the site of appendage ligation, do you still use that
procedure?
Dr Benussi. No, I have never used a purse-string suture on the
appendage at all. I think the results from the Cleveland Clinic
attest to two very important conclusions. First, you cannot do
a purse-string suture and go awaywith that very easily.We do a dou-
ble-layer mattress followed by over-and-over continuous suture of
the appendage very meticulously, spending 2 to 3 minutes on that.
Second, you should not expand too much the indications to prophy-
lactic appendage closure because, actually, endoleaks are a potential
problem and, of course, a partially occluded left appendage is the
worse case scenario as far as the stroke risk is considered.
Dr Jason Bowles (St George, Utah). I have one quick question
on the technical aspects. If you are monitoring the conduction block
on the RPVs and it takes between 2 and 5 applications of your
device, how many times are you applying your device on all the
other lesions sets, and does that influence what you do on the other
side?
Dr Benussi. That is a very good point. Actually, it is the main
message from the whole study. Before doing this study with this
device, we would do maybe two or three ablations. However, after
doing this, I think either you need pacing validation for all the lines,
as we said, or you need to do multiple ablations. If you want to do it
by eyeballing, you have to base that on the thickness of the tissue
you see, how much fat is on the PVs, but never less than three
and probably four or five lines around a PV couple.gery c May 2010
